A this-is-not-rocket-science finding: Terminal cancer patients who don’t have chemotherapy have better quality of life than those who do
Providing further evidence of the blind alley that orthodox approaches to cancer treatment are now lost in, a new study published in the Journal of the American Medical Association (JAMA) has confirmed that chemotherapy does not extend life for cancer patients diagnosed as terminal. Far from being of benefit, the researchers found the treatment was associated with a reduced quality of life in patients who were otherwise in reasonable health and active at the start of the study. Moreover, in yet another this-is-not-rocket-science finding, terminal cancer patients who didn’t have chemotherapy were shown to have a better quality of life than those who did.
Surprising as it might sound, terminal cancer patients are frequently given chemotherapy on the absurd presumption that “there is no harm in trying”. What they aren’t told, however, is that chemotherapy is extraordinarily toxic at any stage of treatment and contributes to a quarter of deaths from cancer. Moreover, the overall contribution of chemotherapy to 5-year cancer survival in adults has been estimated to be a mere 2.3% in Australia and 2.1% in the United States.
Chemotherapy affects not just cancer cells but all of the body’s organs and cell systems. As such, for most patients, each cycle of these poisonous drugs results not only in severe pain but also a multitude of additional health problems. In order to help patients cope with this, more drugs are prescribed. These inevitably result in their suffering still further side effects and additional misery. Nevertheless, despite there being no significant benefit to all this, in many patients chemotherapy continues to be administered almost right up to the point of death.
Ultimately, the only beneficiary from this torturous practice is the trillion-dollar-a-year pharmaceutical ‘business with disease’, for whom oncology drugs are now its highest-earning therapy area. Sales of drugs for cancer now exceed $74 billion dollars a year, with sales of painkillers and other classes of drugs contributing still further to the profit the pharma industry makes from this disease.
But with a chronic deficiency of vitamins, amino acids and other specific micronutrients now known to be the primary cause of today’s most common chronic diseases, drugs are not – and will never be – a cure for cancer. Instead, and as growing numbers of patients around the world now know, victory over cancer is possible using safe, effective, natural approaches.
Research conducted at the Dr. Rath Research Institute has already shown how cancers of the pancreas, breast, bone, prostate, colon, lung and others can be controlled using the micronutrient synergy approach. Through the proper selection and correct combining of micronutrients, there is now no doubt that cancer can be a controllable disease. The sooner more of us are active in telling as many people as possible about this, the sooner painful deaths resulting from chemotherapy and cancer can become a thing of the past.
30 July, 2015
- Brussels EU Regulators Blatantly Ignoring Toxic Effects Of Pesticide Cocktails In Foods
- International Tribunal Accuses Monsanto Of Committing ‘Ecocide’
- Who Knows What’s Best For Your Children? You? Or The Government?
- Long-Term Use Of Antibiotics May Raise Risk Of Bowel Cancer
- Demise Of The Brussels EU Moves Closer: UK Government Issues Formal Notice Of Intention To Leave
- Death Of David Rockefeller At 101: Media Obituaries Ignore His Central Role In Bilderberg Group
- Study Finds High-Dose B Vitamins Have Protective Effect Against Air Pollution